Hướng đến sự ưu tiên của các tế bào lympho xâm nhập khối u ở chuột mang khối u

Agah R, Shau H, Mazumder A (1987) Lysosome rich cells contain the lytic activity of lymphokine-activated killer cell populations. Cancer Immunol Immunother 24:247 Akporiaye ET, Kudalore M, Stevenson AP, Kraemer PM, Stewart CC (1988) Isolation and reactivity of host effectors associated with the manifestation of concomitant tumor immunity. Cancer Res 48:1153 Allavena P, Merendino A, DiBello M, Pirelli A, Rossini S, Mantovani A (1986) Mechanisms of natural cell-mediated resistance in human solid tumors. Biochim Biophys Acta 865:281 Anderson TM, Ibayashi Y, Holmes EC, Golub SH (1987) Modification of natural killer activity of lymphocytes infiltrating human lung cancers. Cancer Immunol Immunother 25:65 Anderson TM, Ibayashi Y, Tokuda Y, Colquhoun SD, Holmes EC, Golub SH (1988) Effects of systemic recombinant interleukin-2 on natural killer and lymphokine activated killer activity of human tumor infiltrating lymphocytes. Cancer Res 48:1180 Belldegrun A, Muul LM, Rosenberg SA (1988) Interleukin 2 expanded tumor-infiltrating lymphocytes in human renal cell cancer: isolation, characterization, and antitumor activity. Cancer Res 48:206 Cikes M, Friberg S, Klein G (1973) Progressive loss of H-2 antigens with concomitant increase of cell-surface antigen(s) determined by Moloney leukemia virus in cultured murine lymphomas. J Natl Cancer Inst 50:347 Cotran RS, Pober JS, Gimbrone MA, Springer TA, Wiebke EA, Gaspari AA, Rosenberg SA, Lotze MT (1987) Endothelial activation during interleukin 2 immunotherapy. J Immunol 139:1883 Ettinghausen SE, Moore JG, White DE, Platanias L, Young NS, Rosenberg SA (1987) Hematologic effects of immunotherapy with lymphokine-activated killer cells and recombinant interleukin-2 in cancer patients. Blood 69:1654 Fujimori Y, Hara H, Nagai K (1987) Effect of lymphokine-activated killer cell fraction on the development of human hematopoietic cells. Cancer Res 48:534 Garcia AM, Gagne GM, Ames IH, Stiteler W, Tomar RH, McAfee JG (1988) Migratory patterns of different indium-111 labeled leukocyte populations (chiefly lymphocytes) from control and thymectomized rats. J Nucl Med 29:83 Grimm EA, Rosenberg SA (1984) The human lymphokine-activated cell phenomenon. Lymphokines 9:279 Honsik CJ, Jung G, Reisfeld RA (1986) Lymphokine-activated killer cells targeted by monoclonal antibodies to the disialogangliosides GD 2 and GD 3 specifically lyse human tumor cells of neuroectodermal origin. Proc Natl Acad Sci USA 83:7893 Itoh K, Tilden AB, Balch CM (1986) Interleukin 2 activation of cytotoxic T-lymphocytes infiltrating into human metastatic melanomas. Cancer Res 46:3011 Julius MH, Simpson E, Herzenberg LA (1973) A rapid method for the isolation of functional thymus-derived murine lymphocytes. Eur J Immunol 3:645 Kedar E, Weiss DW (1983) The in vitro generation of effector lymphocytes and their employment in tumor immunotherapy. Adv Cancer Res 38:171 Kimoto Y, Taguchi T (1987) Adoptive immunotherapy of malignant diseases with IL-2-activated lymphocytes. Biken J 30:29 Kradin RL, Boyle LA, Preffer FI, Callahan RJ, Barlai-Kovach M, Strauss HW, Dubinett S, Kurnick JT (1987) Tumorderived interleukin-2-dependent lymphocytes in adoptive immunotherapy of lung cancer. Cancer Immunol Immunother 24:76 Lafreniere R, Rosenberg SA (1985) Successful immunotherapy of murine experimental hepatic metastases with lymphokine-activated killer cells and recombinant interleukin 2. Cancer Res 45:3735 Lafreniere R, Rosenberg SA (1985) Adoptive immunotherapy of murine hepatic metastases with lymphokine activated killer (LAK) cells and recombinant interleukin-2 (RIL-2) can mediate the regression of both immunogenic and nonimmunogenic sarcomas and an adenocarcinoma. J Immunol 135:4273 Lotze MT, Line BR, Mathisen DJ, Rosenberg SA (1980) The in vivo distribution of autologous human and murine lymphoid cells grown in T cell growth factor (TCGF): implications for the adoptive immunotherapy of tumors. J Immunol 125:1487 Lotze MT, Grimm EA, Mazumder A, Strausser JL, Rosenberg SA (1981) Lysis of fresh and cultured autologous tumor by human lymphocytes cultured in T-cell growth factor. Cancer Res 41:4420 Loudon WG, Abraham SR, Owen-Schaub LB, Hemingway LL, Hemstreet GP, DeBault LE (1988) Identification and selection of human lymphokine activated killer cell effectors and novel recycling intermediates by unique light-scattering properties. Cancer Res 48:2184 Mazumder A, Rosenberg SA (1984) Successful immunotherapy of natural killer resistant established pulmonary melanoma metastases by the intravenous adoptive transfer of syngeneic lymphocytes activated in vitro by interleukin 2. J Exp Med 159:495 Mazumder A, Eberlein TJ, Grimm EA, Wilson DJ, Keenan AM, Aamodt R, Rosenberg SA (1984) Phase 1 study of the adoptive immunotherapy of human cancer with lectin activated autologous mononuclear cells. Cancer 53:896 Mukherji B, Arnbjarnarson O, Spitznagle LA, Hoffman J, Ergin MT, Spencer RP (1987) Biodistribution of in-111 labeled tumor sensitized autologus lymphocytes in cancer patients. In: Truitt RL, Gale RP, Bortin MM (eds) Cellular immunotherapy of cancer. Alan R. Liss, New York, p 325 Mule JJ, Shu S, Schwarz SL, Rosenberg SA (1984) Adoptive immunotherapy of established pulmonary metastases with LAK cells and recombinant interleukin-2. Science 225:1487 Muul LM, Spiess PJ, Director EP, Rosenberg SA (1987) Identification of specific cytolytic immune responses against autologous tumor in humans bearing malignant melanoma. J Immunol 138:989 Nishimura T, Yagi H, Uchiyama Y, Hashimoto Y (1986) Generation of lymphokine-activated killer (LAK) cells from tumor-infiltrating lymphocytes. Cell Immunol 100:149 Ortaldo JR (1986) Cytotoxicity by natural killer cells: Analysis of large granular lymphocytes. Methods Enzymol 132:445 Owen-Schaub LB, Abraham SR, Hemstreet GP (1986) Phenotypic characterization of murine lymphokine-activated killer cells. Cell Immunol 103:272 Rabinowich H, Cohen R, Bruderman I, Steiner Z, Klajman A (1987) Functional analysis of mononuclear cells infiltrating into tumors: lysis of autologous human tumor cells by cultured infiltrating lymphocytes. Cancer Res 47:173 Reynolds CW, Denn AC, Barlozzari T, Wiltrout RH, Reichardt DA, Herberman RB (1984) Natural killer activity in the rat. IV. Distribution of large granular lymphocytes (LGL) following intravenous and intraperitoneal transfer. Cell Immunol 86:371 Rolstad B, Herberman RB, Reynolds CW (1986) Natural killer cell activity in the rat. V. The circulation patterns and tissue localization of peripheral blood large granular lymphocytes (LGL). J Immunol 136:2800 Rosenberg SA (1984) Adoptive immunotherapy of cancer: accomplishments and prospects. Cancer Treat Rep 68:233 Rosenberg SA (1984) Immunotherapy of cancer by the systemic administration of lymphoid cells plus interleukin-2. J Biol Response Mod 3:501 Rosenberg SA (1988) Immunotherapy of cancer using interleukin 2: current status and future prospects. Immunol Today 9:58 Rosenberg SA, Terry WD (1977) Passive immunotherapy of cancer in animals and man. Adv Cancer Res 25:323 Rosenberg SA, Spiess P, Lafreniere R (1986) A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes. Science 233:1318 Silvennoinen O, Hurme M (1988) Simultaneous development of cells with large granular lymphocyte (LGL) morphology and natural killer (NK) cell lytic activity after bone marrow (BM) transplantation in mice. Immunology 63:105 Takai N, Tanaka R, Yoshida S, Hara N, Saito T (1988) In vivo and in vitro effect of adoptive immunotherapy of experimental murine brain tumors using lymphokine-activated killer cells. Cancer Res 48:2047 Topalian SL, Solomon D, Avis FP, Chang AE, Freerksen DL, Linehan WM, Lotze MT, Robertson CN, Seipp CA, Simon P, Simpson CG, Rosenberg SA (1988) Immunotherapy of patients with advanced cancer using tumor-infiltrating lymphocytes and recombinant interleukin-2: a pilot study. J Clin Oncol 6:839 von Kleist S, Berling J, Bohle W, Wittekind C (1987) Immunohistological analysis of lymphocyte subpopulations infiltrating breast carcinomas and benign lesions. Int J Cancer 40:18 Wei W-Z, Heppner G (1987) Natural killer activity of lymphocytic infiltrates in mouse mammary lesions. Br J Cancer 55:589 Wei W-Z, Malone K, Mahoney K, Heppner G (1986) Characterization of lymphocytic infiltrates in normal, preneoplastic, and neoplastic mouse mammary tissues. Cancer Res 46:2680 West WH, Tauer KW, Yannelli JR, Marshall GD, Orr DW, Thurman GB, Oldham RK (1987) Constant infusion recombinant interleukin-2 in adoptive immunotherapy of advanced cancer. N Engl J Med 316:898 Whiteside TL, Miescher S, Hurlimann J, Moretta L, von Fliedner V (1986) Clonal analysis and in situ characterization of lymphocytes infiltrating human breast carcinomas. Cancer Immunol Immunother: 23 169 Yamaki T, Uede T, Shijubo N, Kikuchi K (1988) Functional analysis of mononuclear cells infiltrating into tumors. III. Soluble factors involved in the regulation of T lymphocyte infiltration into tumors. J Immunol 140:4388 Yron I, Wood TA, Spiess PJ, Rosenberg SA (1980) In vitro growth of murine T cells. V. The isolation and growth of lymphoid cells infiltrating syngeneic solid tumors. J Immunol 125:238 Zarcone D, Prasthofer EF, Malavasi F, Pistoia V, LoBuglio AF, Grossi CE (1987) Ultrastructural analysis of human natural killer cell activation. Blood 69:1725